Ask The Recruiter

Vera Therapeutics, Inc.

Pay Change, last update 1 day ago

Pharma biotech · Headquarters United States

Everything we hold on Vera Therapeutics, Inc., newest first. Every line links to the filing or report it came from.

5 updates tracked
1 leadership change
31 Dec 2023 tracked since
United States where
  1. 2026-08-15
    Pay Change Pay and benefits

    Vera Therapeutics, Inc. advertises a median posted salary band of $175,000 to $210,000 across 13 open roles

    Advertised bands move before published pay data does, because they are set by what an employer thinks it must offer to fill a role today. Read the direction across postings rather than any one band, and remember this is the ask, not the settlement.

    News Report · Greenhouse job board · No archive snapshot yet. We re-check weekly; next check by Aug 23.

  2. 2026-03-09
    Headcount Not Stated Leadership moves

    Vera Therapeutics, Inc. 8-K filing (Item 5.02): officer or director change

    Christopher Hite joins Vera Therapeutics' board, with a stock option grant as part of his compensation. The announcement does not disclose any changes to hiring plans.

    United States · Official Filing · SEC EDGAR

  3. 2025-12-31
    Pay Change Pay and benefits

    Vera Therapeutics, Inc.: $6,986,410 total compensation for the principal executive officer, fiscal year ended 2025-12-31

    Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.

    United States · Official Filing · SEC EDGAR (pay-versus-performance)

  4. 2024-12-31
    Pay Change Pay and benefits

    Vera Therapeutics, Inc.: $5,648,201 total compensation for the principal executive officer, fiscal year ended 2024-12-31

    Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.

    United States · Official Filing · SEC EDGAR (pay-versus-performance)

  5. 2023-12-31
    Pay Change Pay and benefits

    Vera Therapeutics, Inc.: $3,429,733 total compensation for the principal executive officer, fiscal year ended 2023-12-31

    Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.

    United States · Official Filing · SEC EDGAR (pay-versus-performance)

The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker